UK markets closed

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
37.40-0.14 (-0.37%)
At close: 10:25AM CET

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Strasse 10
Berlin 13125
Germany
49 30 94 10 84 0
https://www.ezag.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,075

Key executives

NameTitlePayExercisedYear born
Dr. Harald HasselmannCEO & Chairman of the Executive Board of Medical Segment293.11kN/A1967
Ms. Jutta LudwigMember of Executive Board of Asia Business24kN/A1953
Mr. Franklin B. YeagerPresident of Eckert and Ziegler Isotope Products Inc. & Member of Executive BoardN/AN/AN/A
Dr. Gunnar MannHead of Intragroup ServicesN/AN/A1967
Ivan SimmerManaging Director of Eckert & Ziegler Cesio s.r.o.N/AN/AN/A
Mr. Joseph HathcockVice President of Eckert & Ziegler Isotope Products Inc.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Eckert & Ziegler SE, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, and other consumables. The Isotope Products segment manufactures and sells standard and radiation sources for medical and industrial sectors. This segment offers calibration related sources for radioisotopes. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is based in Berlin, Germany.

Corporate governance

Eckert & Ziegler Strahlen- und Medizintechnik AG’s ISS governance QualityScore as of 1 March 2024 is 5. The pillar scores are Audit: 6; Board: 6; Shareholder rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.